Two Cases of Neuroendocrine Transformation of Prostate Carcinoma in the Era of Expanding Therapeutic Options: Do the Increased Number of Available Treatments Translate Into Improved Patient Outcomes?
1/5 보강
Neuroendocrine prostate cancer is an aggressive and increasingly recognized resistance phenotype arising in advanced prostate adenocarcinoma, particularly after prolonged androgen receptor-directed th
APA
Aranha R, Veiga F, et al. (2025). Two Cases of Neuroendocrine Transformation of Prostate Carcinoma in the Era of Expanding Therapeutic Options: Do the Increased Number of Available Treatments Translate Into Improved Patient Outcomes?. Cureus, 17(12), e99831. https://doi.org/10.7759/cureus.99831
MLA
Aranha R, et al.. "Two Cases of Neuroendocrine Transformation of Prostate Carcinoma in the Era of Expanding Therapeutic Options: Do the Increased Number of Available Treatments Translate Into Improved Patient Outcomes?." Cureus, vol. 17, no. 12, 2025, pp. e99831.
PMID
41573423 ↗
Abstract 한글 요약
Neuroendocrine prostate cancer is an aggressive and increasingly recognized resistance phenotype arising in advanced prostate adenocarcinoma, particularly after prolonged androgen receptor-directed therapy. We describe two patients with metastatic prostate cancer who developed rapid clinical progression accompanied by disproportionately low prostate-specific antigen (PSA) levels, ultimately revealing transformation to neuroendocrine carcinoma. These cases highlight the diagnostic challenges associated with this entity, the importance of obtaining new tissue for histologic confirmation when radiologic progression diverges from biochemical markers, and the limited effectiveness of current therapeutic options. Overall, these cases emphasize the critical need for improved clinical recognition and for continued research into targeted therapeutic approaches capable of addressing this highly aggressive phenotype.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.
- The Role of Immune Infiltration and Oxidative Stress in the Progression of Cerebral Cavernous Malformation.
- TIM-3 inhibition enhances breast tumor progression and metastasis: A paradoxical immune checkpoint response.
- CHI3L1 Is Associated With TP53 Signaling and Promotes Papillary Thyroid Carcinoma Progression.
- The tumor microenvironment shapes gastric cancer progression by coordinating immune suppression and metabolic reprogramming.
- Targeting LIPA with ERX-41 Induces ER Stress and Inhibits Tumor Progression in Inflammatory Breast Cancer.